Related Articles
Knockdown of FUSE binding protein 1 enhances the sensitivity of epithelial ovarian cancer cells to carboplatin
FBP1 promotes ovarian cancer development through the acceleration of cell cycle transition and metastasis
Fuse-binding protein 1 is a target of the EZH2 inhibitor GSK343, in osteosarcoma cells
High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity Corrigendum in /10.3892/ijo.2021.5210
Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer